Project 2: Tau uptake mechanisms and neuronal excitability in FTD
项目 2:FTD 中的 Tau 摄取机制和神经元兴奋性
基本信息
- 批准号:10011930
- 负责人:
- 金额:$ 29.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-30 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:Action PotentialsAddressAffectAnticodonAstrocytesAxonBackBindingCRISPR interferenceCaliforniaCategoriesCell LineCellsCellular StressCharacteristicsCollaborationsCollectionComputer softwareCultured CellsDataDefectDendritesDetectionDevicesElectrophysiology (science)EnzymesEventFunctional disorderFutureGAG GeneGene ExpressionGenesGerm CellsGrowthHarvestHeparan Sulfate ProteoglycanHumanInstitutesInvestigationLabelLeadLinkMeasuresMediatingMethodsMicroarray AnalysisNeuronsPathogenicityPathologicPathologyPathway interactionsPatternPhenotypePhysicsPolysaccharidesPopulationPreparationProcessRNAResolutionRestRoleSignal TransductionSmall RNAStressSystemTechniquesTechnologyTestingTimeTrainingTransfer RNATranslationsanalytical toolbasecollaborative approachdesigndifferential expressionfallsinduced pluripotent stem cellinstrumentationinterestmembermillisecondmulti-electrode arraysneuronal excitabilitynovelprogramsproteostasisrelating to nervous systemsingle-cell RNA sequencingsmall moleculestress granuletau Proteinstau aggregationtau conformationtau mutationtooltranscriptome sequencingtranscriptomicsuptake
项目摘要
PROJECT SUMMARY/ABSTRACT — PROJECT 2
Many unknown pathogenic steps lie between normal tau protein in a healthy neuron and the cellular
dysfunction that occurs as a result of tau uptake and aggregation. The aims address two emerging facets of
the pathobiology: the mechanism of tau uptake in neurons and astrocytes and the effects of tau inclusions on a
set of functional cellular parameters. Tau uptake will be studied using a highly novel and highly collaborative
approach called CRISPRi to identify in a nonbiased manner genes involved in tau uptake followed by
functional studies, which will validate the CRISPRi hits. A more focused approach to uptake will focus on
HSPGs with a GAG microarray panel to identify HSPG chain features to which tau can bind specifically. Once
tau is inside the cell we ask what are the effects of tau inclusions or tau mutations in human iPSCderived
neurons. We have synthesized multiple types of tau aggregates and studied their uptake conditions. A variety
of techniques will be applied to pinpoint cellular defects due to the burden of tau inclusions. These techniques
fall into two categories—expression sequencing and electrophysiological assessment. With regard to the
former, the strength of our proposal is the use of single cell RNAseq to identify precisely gene expression
changes in cells with tau inclusions compared to its neighbors that do not have tau inclusions. A further
strength is the data that supports our hypothesis concerning the role of tRNA in triggering tau conformational
changes that may lead to aggregation as well as an investigation of the role of cellular stress in inducing tRNA
cleavage and the formation of half tRNAs known as tiRNAs. We have also hypothesized that tau can induce
electrophysiologic dysfunction and over the past three years in collaboration with the physics department have
built tools capable of detecting conduction deficits, alterations in the action potential at the axonal initial
segment and hyerexcitability. The detection methods utilize a multielectrode array (MEA) platform, modified
MEAs that are patterned to confine neuron growth and direct signaling between neuronal ensembles, analytical
tools for spike trains, and an automated cell harvesting device. The delineation of the effects on tau mutations
and tau inclusions on cultured cells is a cellular phenotype that is not welldescribed in the field, but will be
necessary in the future for small molecule screens. Working interchangeably with several cellular systems will
allow us to select the ideal context for each experimental question posed and explore multiple facets in a
search for taurelated cellular phenotypes. This proposal rests on strong interactions among all the team
members.
项目摘要/摘要-项目2
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH Stephen KOSIK其他文献
KENNETH Stephen KOSIK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH Stephen KOSIK', 18)}}的其他基金
A novel approach to restricting the spread of neurofibrillary tau
限制神经原纤维 tau 蛋白扩散的新方法
- 批准号:
10327251 - 财政年份:2021
- 资助金额:
$ 29.61万 - 项目类别:
A novel approach to restricting the spread of neurofibrillary tau
限制神经原纤维 tau 蛋白扩散的新方法
- 批准号:
10679282 - 财政年份:2021
- 资助金额:
$ 29.61万 - 项目类别:
A novel approach to restricting the spread of neurofibrillary tau
限制神经原纤维 tau 蛋白扩散的新方法
- 批准号:
10579696 - 财政年份:2021
- 资助金额:
$ 29.61万 - 项目类别:
A novel approach to restricting the spread of neurofibrillary tau
限制神经原纤维 tau 蛋白扩散的新方法
- 批准号:
10478173 - 财政年份:2021
- 资助金额:
$ 29.61万 - 项目类别:
The complex interaction between Alzheimer drivers and aging
阿尔茨海默病驱动因素与衰老之间复杂的相互作用
- 批准号:
9708308 - 财政年份:2020
- 资助金额:
$ 29.61万 - 项目类别:
The complex interaction between Alzheimer drivers and aging
阿尔茨海默病驱动因素与衰老之间复杂的相互作用
- 批准号:
9892174 - 财政年份:2019
- 资助金额:
$ 29.61万 - 项目类别:
Development of RNAi as Treatment for Neurodegeneration
RNAi 治疗神经退行性疾病的发展
- 批准号:
7634459 - 财政年份:2007
- 资助金额:
$ 29.61万 - 项目类别:
Development of RNAi as Treatment for Neurodegeneration
RNAi 治疗神经退行性疾病的发展
- 批准号:
8084139 - 财政年份:2007
- 资助金额:
$ 29.61万 - 项目类别:
Development of RNAi as Treatment for Neurodegeneration
RNAi 治疗神经退行性疾病的发展
- 批准号:
7879951 - 财政年份:2007
- 资助金额:
$ 29.61万 - 项目类别:
Development of RNAi as Treatment for Neurodegeneration
RNAi 治疗神经退行性疾病的发展
- 批准号:
7234487 - 财政年份:2007
- 资助金额:
$ 29.61万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 29.61万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 29.61万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 29.61万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 29.61万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 29.61万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 29.61万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 29.61万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 29.61万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 29.61万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 29.61万 - 项目类别:
Research Grant